Mareckova, Helena <br/><br/>
Natalizumab in the treatment of patients with multiple sclerosis: first experience.  [electronic resource] 

 -  Annals of the New York Academy of Sciences  Sep 2007 
 - 465-73 p.  digital 
<br/><br/> Publication Type: Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0077-8923 
<br/><br/><label>Standard No.: </label>10.1196/annals.1423.049  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Humanized<br/>CD4-Positive T-Lymphocytes--drug effects<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Multiple Sclerosis--cerebrospinal fluid<br/>Natalizumab<br/>Receptors, CCR5--metabolism<br/>Receptors, CXCR3--metabolism